EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens

Tina Peiter, Fergus de Grey-Warter, Tessa Stahl, Thomas Hallet, Derek Matthews, Maren Eggers

GMS Hygiene and Infection Control · 24.02.2025 · 20 (Doc01) · Doc01

DOI: 10.3205/dgkh000530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 24.02.2025. Verfasst von Tina Peiter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Reckitt Benckiser Deutschland GmbH, Heidelberg, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Too often, antibiotics are prescribed in the treatment of pharyngitis, which can contribute to antimicrobial resistance. We aimed to assess the in vitro antiviral and antimicrobial activity of sugar-free cetylpyridinium chloride (CPC)/benzocaine lozenges, which can potentially offer a more suitable treatment for pharyngitis.

Methods

The antiviral activity of sugar-free CPC/benzocaine (1.4 mg/10 mg) lozenges (Dolo-Dobendan 1.4 mg/10 mg lozenges) was assessed using the DIN EN 14476:2019–10 suspension test against bovine coronavirus (S379 Reims) or influenza virus A (H1N1/Brisbane/59/2007) under clean and dirty conditions. Viral titers were measured after 1, 5, 10, and 30 min exposure; a reduction of ≥4 lg was considered virucidal. For bovine coronavirus, large volume plating was used due to cytotoxicity. Antimicrobial activity was measured against 11 microorganisms associated with pharyngitis, with contact times of 1, 5, and 10 min (+30 min for positive control).

Results

For influenza, sugar-free lozenges showed ≥4 lg efficacy from 5 and 10 min exposure under clean and dirty conditions, respectively. For bovine coronavirus, sugar-free lozenges exhibited ≥4 lg efficacy at 10 min under both conditions. Bactericidal activity was observed against nine of the challenge microorganisms within 5 min, with plate counts of

Schlagwörter

Stichwörter der Autor:innen

antibacterial agentantiseptic agentbenzocainebovine coronaviruscetylpyridiniumdrug resistanceinfluenza virus Alozengespharyngitisvirucidal agent

Autor:innen und Institutionen

  • Reckitt Benckiser Deutschland GmbH, Heidelberg, Germany.
  • Reckitt Benckiser Healthcare Ltd, Hull, United Kingdom.
  • Reckitt Benckiser Healthcare Ltd, Slough, United Kingdom.
  • Labor Prof. Gisela Enders MVZ GbR, Stuttgart, Germany.

Zitieren

APA

Peiter, T., de Grey-Warter, F., Stahl, T., Hallet, T., Matthews, D., & Eggers, M. (2025). Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens. GMS Hygiene and Infection Control, 20(Doc01), Doc01. https://doi.org/10.3205/dgkh000530

Vancouver

Peiter T, de Grey-Warter F, Stahl T, Hallet T, Matthews D, Eggers M. Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens. GMS Hygiene and Infection Control. 2025;20(Doc01):Doc01. doi:10.3205/dgkh000530

BibTeX
@article{Peiter2025,
  author = {Peiter, Tina and de Grey-Warter, Fergus and Stahl, Tessa and Hallet, Thomas and Matthews, Derek and Eggers, Maren},
  title = {Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens},
  journal = {GMS Hygiene and Infection Control},
  year = {2025},
  volume = {20},
  number = {Doc01},
  pages = {Doc01},
  doi = {10.3205/dgkh000530}
}
Kostenlos starten →